Precipio is trading 11.56% up at $27.55 after investors continued reacting to its August 17, 2026, second-quarter results.

  • Revenue reached record $7.0 million, up 22% year over year; adjusted EBITDA turned positive at $400,000.
  • Operating cash flow reached $700,000, while management cited continued product growth, a stronger commercial pipeline, and operating leverage into the second half.
  • Healthcare’s broader rally likely provided additional support, but the earnings update is the clearest catalyst. Trading remains active during the regular session.